IC

Isan Chen

Chief Executive Officer

Treadwell Therapeutics, Inc.

San Diego, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Treadwell Therapeutics, Inc.
Industry
research
Employees
15.0
Seniority
C suite
Total Funding
118000000.0
Latest Funding
Series B

Technologies

Outlook WP Engine Greenhouse.io Vimeo BugHerd Mobile Friendly Gravity Forms Google Tag Manager reCAPTCHA WordPress.org Remote

Keywords

biotechnology research oncology drug discovery clinical stage therapeutic intervention novel targets biologics small molecule t-cell receptor therapy pipeline cancer treatment research & development clinical trials first-in-class immune-oncology plk4 inhibitor ttk inhibitor hpk1 inhibitor biologic programs targeted therapy acute myeloid leukemia er+ breast cancer triple negative breast cancer solid tumors liquid tumors genomic instability cancer cell proliferation cancer patient clinical development expanded access compassionate use cancer therapies dysregulated pathways targeting mitosis functional genomics rnai screens tcr identification high-throughput screening cancer genomics tumor profiling research collaborators investigational drugs biotechnology biopharma clinical candidates drug development therapeutic modalities hospital & health care health care health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans